Abstract:Primary ovarian insufficiency (POI) is one of the most intractable causes of infertility in women of childbearing age. In recent years, the incidence of POI is increasing and the proportion of patients become younger in average age, which seriously affects women's physical and mental health. The etiology of POI is diverse and complex, and its pathogenesis is not very clear. At present, hormone replacement therapy (HRT), oocyte donation and in vitro activation (IVA) technology are mainly used in clinical treatment, but they cannot fundamentally improve ovarian function. Mesenchymal stem cell (MSC) is a kind of cell with multi-directional differentiation potential. It has been proved that MSC has certain therapeutic effect on a variety of diseases in preclinical experimental research, but the related mechanism of its treatment is still unclear. Exosomes are small vesicles secreted by cells and carry a variety of bioactive substances. In recent years, exosomes have shown great potential in the treatment of disease and its related mechanisms research. In this paper, the progress of exosomes derived from MSC in the treatment of POI and its possible mechanism are discussed, and its development prospect in this field is prospected.

Research progress on the mechanism of exosomes derived from mesenchymal stem cell in the treatment of primary ovarian insufficiency